The prevalence of mitochondrial mutations associated with aminoglycoside-induced deafness in ethnic Latvian population: the appraisal of the evidence
Authors:
Open Access
- 6 December 2018
- journal article
- research article
- Published by Springer Nature in Journal of Human Genetics
- Vol. 64 (3) , 199-206
Abstract
Aminoglycosides are potent antibiotics which are used to treat severe gram-negative infections, neonatal sepsis, and multidrug-resistant tuberculosis. Ototoxicity is a well-known side effect of aminoglycosides, and a rapid, profound, and irreversible hearing loss can occur in predisposed individuals. MT-RNR1 gene encoding the mitochondrial ribosomal 12S subunit is a hot spot for aminoglycoside-induced hearing loss mutations, however, a variability in the nature and frequency of genetic changes in different populations exists. The objective of this study was to analyze MT-RNR1 gene mutations in a Baltic-speaking Latvian population, and to estimate the prevalence of such genetic changes in the population-specific mitochondrial haplogroups. In the cohort of 191 ethnic non-related Latvians, the presence of two deafness-associated mutations, m.1555A>G and m.827A>G, three potentially pathogenic variations, m.961insC(n), m.961T>G and m.951G>A, and one unknown substitution, m961T>A was detected, and the aggregate frequency of all variants was 7.3%. All genetic changes were detected in samples belonged to the haplogroups H, U, T, and J. The presence of several aminoglycoside ototoxicity-related MT-RNR1 gene mutations in Baltic-speaking Latvian population indicates the necessity to include ototoxicity-related mutation analysis in the future studies in order to determine the feasibility of DNA screening for patients before administration of aminoglycoside therapy.Keywords
Funding Information
- Izglītības un zinātnes ministrija (VPP)
This publication has 46 references indexed in Scilit:
- Mitochondrial haplogroup B increases the risk for hearing loss among the Eastern Asian pedigrees carrying 12S rRNA 1555A>G mutationProtein & Cell, 2015
- Treatment of Infectious Diseases2012
- The prevalence of mitochondrial mutations associated with aminoglycoside‐induced sensorineural hearing loss in an NICU populationThe Laryngoscope, 2011
- Mutation analysis of mitochondrial 12S rRNA gene in Polish patients with non-syndromic and aminoglycoside-induced hearing lossBiochemical and Biophysical Research Communications, 2010
- Updated comprehensive phylogenetic tree of global human mitochondrial DNA variationHuman Mutation, 2008
- Maternally inherited non-syndromic hearing loss associated with mitochondrial 12S rRNA A827G mutation in a Chinese familyBiochemical and Biophysical Research Communications, 2006
- Cochlear alterations in deaf and unaffected subjects carrying the deafness-associated A1555G mutation in the mitochondrial 12S rRNA geneBiochemical and Biophysical Research Communications, 2006
- Mutational analysis of the mitochondrial 12S rRNA gene in Chinese pediatric subjects with aminoglycoside-induced and non-syndromic hearing lossHuman Genetics, 2005
- A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathyAnnals of Neurology, 2000
- Auditory Ototoxicity in Tuberculosis Patients Treated with DihydrostreptomycinJAMA, 1963